Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance

被引:29
|
作者
Maheshwari, HG
Pezzoli, SS
Rahim, A
Shalet, SM
Thorner, MO
Baumann, G
机构
[1] Northwestern Univ, Sch Med, Dept Med, Ctr Endocrinol Metab & Mol Med, Chicago, IL 60611 USA
[2] Vet Adm Chicago Hlth Syst, Lakeside Div, Chicago, IL 60611 USA
[3] Univ Virginia Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA
[4] Christie Hosp, Dept Endocrinol, Manchester M20 4BX, Lancs, England
来源
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM | 2002年 / 282卷 / 04期
关键词
growth hormone-releasing hormone receptor; somatostatin; pituitary gland; short stature;
D O I
10.1152/ajpendo.00537.2001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growth hormone (GH) secretion is regulated by GH-releasing hormone (GHRH), somatostatin, and possibly ghrelin, but uncertainty remains about the relative contributions of these hypophysiotropic factors to GH pulsatility. Patients with genetic GHRH receptor (GHRH-R) deficiency present an opportunity to examine GH secretory dynamics in the selective absence of GHRH input. We studied circadian GH profiles in four young men homozygous for a null mutation in the GHRH-R gene by use of an ultrasensitive GH assay. Residual GH secretion was pulsatile, with normal pulse frequency, but severely reduced amplitude (<1% normal) and greater than normal process disorder (as assessed by approximate entropy). Nocturnal GH secretion, both basal and pulsatile, was enhanced compared with daytime. We conclude that rhythmic GH secretion persists in an amplitude-miniaturized version in the absence of a GHRH-R signal. The nocturnal enhancement of GH secretion is likely mediated by decreased somatostatin tone. Pulsatility of residual GH secretion may be caused by oscillations in somatostatin and/or ghrelin; it may also reflect intrinsic oscillations in somatotropes.
引用
收藏
页码:E943 / E951
页数:9
相关论文
共 50 条
  • [41] DISCORDANT EFFECTS OF ENDOGENOUS AND EXOGENOUS SOMATOSTATIN ON GROWTH HORMONE-RELEASING HORMONE-SECRETION FROM PERIFUSED MOUSE HYPOTHALAMI
    GIRALDI, FP
    FROHMAN, LA
    NEUROENDOCRINOLOGY, 1995, 61 (05) : 566 - 572
  • [42] Neurotransmitter-mediated action of an antagonist of growth hormone-releasing hormone on anxiolysis in mice
    Telegdy, Gyula
    Schally, Andrew V.
    BEHAVIOURAL BRAIN RESEARCH, 2012, 233 (01) : 232 - 236
  • [43] Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus
    Peterfi, Zoltan
    McGinty, Dennis
    Sarai, Erzsebet
    Szymusiak, Ronald
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 298 (01) : R147 - R156
  • [44] Involvement of neurotransmitters in the action of growth hormone-releasing hormone antagonist on passive avoidance learning
    Telegdy, Gyula
    Schally, Andrew V.
    BEHAVIOURAL BRAIN RESEARCH, 2012, 233 (02) : 326 - 330
  • [45] Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice
    Leone, Sheila
    Chiavaroli, Annalisa
    Recinella, Lucia
    Orlando, Giustino
    Ferrante, Claudio
    Marconi, Guya Diletta
    Gasparo, Irene
    Bitto, Alessandra
    Salvatori, Roberto
    Brunetti, Luigi
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2019, 144
  • [46] CORTICOTROPIN-RELEASING HORMONE, LUTEINIZING-HORMONE-RELEASING HORMONE, GROWTH HORMONE-RELEASING HORMONE, AND SOMATOSTATIN-LIKE IMMUNOREACTIVITIES IN BIOPSIES FROM BREAST-CANCER PATIENTS
    CIOCCA, DR
    PUY, LA
    FASOLI, LC
    TELLO, O
    AZNAR, JC
    GAGO, FE
    PAPA, SI
    SONEGO, R
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 15 (03) : 175 - 184
  • [47] CHANGES IN SERUM GROWTH-HORMONE AND PROLACTIN LEVELS, AND IN HYPOTHALAMIC GROWTH HORMONE-RELEASING HORMONE, THYROTROPIN-RELEASING-HORMONE AND SOMATOSTATIN CONTENT, AFTER SUPERIOR CERVICAL SYMPATHECTOMY IN RATS
    CARDINALI, DP
    ESQUIFINO, AI
    ARCE, A
    VARA, E
    ARIZNAVARRETA, C
    TRESGUERRES, JAF
    NEUROENDOCRINOLOGY, 1994, 59 (01) : 42 - 48
  • [48] PYRIDOSTIGMINE ENHANCES EVEN IF IT DOES NOT NORMALIZE THE GROWTH-HORMONE RESPONSES TO GROWTH HORMONE-RELEASING HORMONE IN PATIENTS WITH CUSHINGS-DISEASE
    GIUSTINA, A
    BOSSONI, S
    BODINI, C
    FERRARI, C
    PIZZOCOLO, G
    SCALVINI, T
    SCHETTINO, M
    WEHRENBERG, WB
    HORMONE RESEARCH, 1991, 35 (3-4) : 99 - 103
  • [49] Substance P appears to affect growth via growth hormone-releasing hormone (GHRH) neurons in the human hypothalamus
    Uhlman, Dustin
    Nguyen, Thomas
    Grignol, George
    Merchenthaler, Istvan
    Dudas, Bertalan
    BRAIN STRUCTURE & FUNCTION, 2019, 224 (06) : 2079 - 2085
  • [50] CLONIDINE POTENTIATES THE GROWTH-HORMONE RESPONSE TO A GROWTH-HORMONE RELEASING HORMONE CHALLENGE IN HYPOTHALAMIC GROWTH-HORMONE RELEASING HORMONE-DEFICIENT RATS
    ARCE, V
    BARROS, MG
    VARA, E
    LIMA, L
    TRESGUERRES, JAF
    DEVESA, J
    NEUROENDOCRINOLOGY, 1995, 61 (05) : 552 - 558